MR Tomography Helps Objectively Determine Breast Density
By MedImaging International staff writers Posted on 13 Mar 2016 |
An automated user-independent breast density (BD) measurement system based on magnetic resonance tomography (MRT) could provide diagnosis and risk assessment.
Researchers at the Medical University of Vienna (Austria) investigated the use of an automated user-independent quantitative volumetric (AUQV) MRT measurement system to compare it with qualitative and quantitative mammographic BD measurements. The study involved 43 women with normal mammogram results who were subjected to BD assessment with MRT using the Dixon technique; to test reproducibility, a second MRT after patient repositioning was performed. The system automatically calculated BD percentage.
Qualitative and quantitative BD was estimated semi-automatically using a thresholding technique, and statistical tests were used to assess the agreement between the two AUQV MRT measurements and compare them with qualitative and quantitative MG BD estimations. The results showed a nearly perfect agreement of AUQV MR BD measurements between the 2 MRT examinations, which were significantly lower than quantitative and qualitative MG BD assessment. The study was presented at the European Congress of Radiologists (ECR), held during March 2016 in Vienna (Austria).
“It works practically at the touch of a button and only takes a few minutes. There is also no need to provide contrast material,” said lead author and study presenter Georg Wengert, MD, of the department of radiology and nuclear medicine at the Medical University of Vienna. “For the first time worldwide, an objective measurement of breast density with fully automatic software and higher precision and reproducibility has been detected with this method, and a prototype currently exists.”
Breast density is divided into four categories according to the guidelines of the American College of Radiology (ACR). Ranging from A to D, the risk of getting breast cancer is considered to be four to six times higher for a higher BD (C/heterogeneous and D/extremely dense). The density cannot be precisely measured using mammography and an ultrasound scan, and additionally a high breast density makes diagnosis more difficult.
Related Links:
Medical University of Vienna
Researchers at the Medical University of Vienna (Austria) investigated the use of an automated user-independent quantitative volumetric (AUQV) MRT measurement system to compare it with qualitative and quantitative mammographic BD measurements. The study involved 43 women with normal mammogram results who were subjected to BD assessment with MRT using the Dixon technique; to test reproducibility, a second MRT after patient repositioning was performed. The system automatically calculated BD percentage.
Qualitative and quantitative BD was estimated semi-automatically using a thresholding technique, and statistical tests were used to assess the agreement between the two AUQV MRT measurements and compare them with qualitative and quantitative MG BD estimations. The results showed a nearly perfect agreement of AUQV MR BD measurements between the 2 MRT examinations, which were significantly lower than quantitative and qualitative MG BD assessment. The study was presented at the European Congress of Radiologists (ECR), held during March 2016 in Vienna (Austria).
“It works practically at the touch of a button and only takes a few minutes. There is also no need to provide contrast material,” said lead author and study presenter Georg Wengert, MD, of the department of radiology and nuclear medicine at the Medical University of Vienna. “For the first time worldwide, an objective measurement of breast density with fully automatic software and higher precision and reproducibility has been detected with this method, and a prototype currently exists.”
Breast density is divided into four categories according to the guidelines of the American College of Radiology (ACR). Ranging from A to D, the risk of getting breast cancer is considered to be four to six times higher for a higher BD (C/heterogeneous and D/extremely dense). The density cannot be precisely measured using mammography and an ultrasound scan, and additionally a high breast density makes diagnosis more difficult.
Related Links:
Medical University of Vienna
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer